Halstonberg
consumer legal coverage

Toxic baby food heavy metals litigation: the Congressional investigation findings, the autism and ADHD claims, the February 2026 expert exclusion ruling, and the current status of the approximately 400 pending cases

Declan DoyleReviewed by Yuki Nakamura, JDOctober 17, 202611 min
Toxic Baby FoodHeavy MetalsAutism LawsuitCongressional Investigation

The toxic baby food litigation is among the most emotionally charged mass torts in the federal system. Parents allege that the baby food they fed their infants, products from brands they trusted, contained dangerously high levels of toxic heavy metals and that the exposure caused their children's autism, ADHD, or other developmental disorders.

The science behind the contamination is not in dispute: a 2021 Congressional investigation documented arsenic, lead, cadmium, and mercury at levels far exceeding federal safety standards for drinking water. The legal question is causation: whether the heavy metal levels in the specific products, consumed in the specific quantities, caused the specific neurological injuries alleged. That question took a substantial hit in February 2026 when the court excluded all of the plaintiffs' general causation experts.

The litigation is real, active, and emotionally significant. It is also, as of 2026, in a precarious legal position. Understanding both the strength of the contamination evidence and the weakness of the current causation posture is essential for anyone evaluating a potential claim.

The contamination evidence

The factual foundation of the litigation rests on three pillars of evidence:

The 2019 HBBF report. In October 2019, Healthy Babies Bright Futures published a report testing 168 baby food products from major brands. The findings: 95% of the tested products contained at least one of four toxic heavy metals (arsenic, lead, cadmium, or mercury). One in four products contained all four.

The 2021 Congressional investigation. The House Subcommittee on Economic and Consumer Policy, Committee on Oversight and Reform, investigated seven major baby food manufacturers and published its findings in February 2021. The report documented contamination levels that were staggering:

Beech-Nut used ingredients containing up to 913.4 parts per billion (ppb) of inorganic arsenic, which is 91 times the FDA's maximum safe level for drinking water (10 ppb). The company regularly used "high-arsenic" additives testing over 300 ppb.

Beech-Nut used ingredients containing up to 886.9 ppb of lead, which is 177 times the FDA's maximum safe level for drinking water (5 ppb).

Multiple manufacturers sold products containing up to 6,441 ppb of lead in their ingredients.

Only one of the investigated companies reported testing for mercury. The others did not test for it at all.

The 2024 follow-up Congressional report. A follow-up investigation found that several manufacturers, including Gerber and Beech-Nut, continued to sell products with measurable levels of arsenic, cadmium, and lead associated with neurological harm in children.

The contamination evidence is compelling. The Congressional investigation established that manufacturers knew their ingredients contained heavy metal levels far exceeding any reasonable safety standard and continued to sell the products.

The defendants and the products

The litigation names multiple major manufacturers:

Gerber (owned by Nestle): infant cereals, purees, snacks, and other baby food products.

Beech-Nut Nutrition Company: jars, cereals, and pouches.

Hain Celestial Group (Earth's Best Organic): organic baby food products marketed as safe and healthy.

Nurture (Happy Family Organics / HappyBABY): organic baby food products.

Plum Organics (formerly owned by Campbell Soup Company): organic purees and snacks.

Walmart (Parent's Choice): store-brand baby food.

Sprout Foods: organic baby food products.

The products include infant rice cereal (which tends to accumulate arsenic from rice), teething biscuits, fruit and vegetable purees, rice cakes, puffs, and other products marketed specifically for infants and toddlers.

The alleged injuries

The plaintiffs allege that chronic exposure to heavy metals through baby food caused neurological and developmental injuries:

Autism spectrum disorder (ASD).

Attention deficit hyperactivity disorder (ADHD).

Developmental delays affecting speech, motor skills, and cognitive function.

The medical basis: heavy metals (particularly lead and arsenic) are established neurotoxins. The FDA and the World Health Organization have confirmed that even small amounts of these metals can cause severe and irreversible damage to infant brain development. The developing brain is particularly vulnerable because of its rapid growth, high metabolic demand, and incomplete blood-brain barrier.

The population-level evidence linking heavy metal exposure to neurodevelopmental harm is well-established. What is legally contested (and what the February 2026 ruling addressed) is the individual causation question: whether the specific quantity of heavy metals consumed by a specific child through specific baby food products caused that child's specific diagnosis.

The February 2026 expert exclusion

In a ruling that substantially weakened the plaintiffs' legal position, Judge Corley granted the defendants' motions to exclude all of the plaintiffs' general causation experts from testifying at trial. The court found that the experts' methodology for estimating the amount of heavy metals consumed by the plaintiff children lacked scientific reliability.

The core problem: the experts could not reliably establish how much heavy metal the individual children actually consumed (the exposure dose), which is essential for proving that the exposure was sufficient to cause the alleged injury. Without reliable dose estimates, the causal chain from "baby food contained heavy metals" to "this child's autism was caused by those heavy metals" breaks down.

The court did not rule that heavy metals cannot cause neurodevelopmental harm (that population-level evidence was not at issue). The ruling addressed the specific methodology used to estimate individual children's exposure from baby food consumption, and found it scientifically unreliable.

Despite the expert exclusion, Judge Corley denied the defendants' motion to dismiss. The cases remain active, and the plaintiffs have the opportunity to retain new experts, develop new exposure methodologies, and attempt to survive future Daubert challenges with improved evidence.

But the expert exclusion is a substantial hurdle. Without qualified experts to establish the exposure dose and the causal link, the cases cannot go to trial on the current evidence. The plaintiffs' attorneys must solve the exposure-estimation problem before the litigation can proceed to bellwether trials.

How this compares to other litigation with causation challenges

The toxic baby food litigation shares the causation challenge with several other Halstonberg-covered mass torts:

Gardasil HPV vaccine (MDL 3036) faces a similar legal posture: summary judgment on preemption grounds, with the litigation's future dependent on an appellate reversal. Both litigations are active but legally imperiled.

Tylenol autism (MDL) involves similar causation challenges, with the question of whether acetaminophen use during pregnancy caused autism in the child. The Daubert analysis of causation experts has been the critical battleground.

Roundup/glyphosate involved similar challenges to the plaintiffs' epidemiological and toxicological evidence, though the Roundup plaintiffs ultimately survived Daubert and won substantial bellwether verdicts. The toxic baby food plaintiffs have not yet achieved that breakthrough.

The causation challenge in the baby food litigation is, in some ways, harder than in pharmaceutical cases: the exposure is to multiple metals across multiple products over an extended period, consumed in unmeasured quantities during a developmental window where many factors (genetics, environment, prenatal exposures) also influence neurodevelopmental outcomes. Isolating the baby food contribution from the baseline background exposure and other risk factors is the scientific and legal challenge.

The FDA's role

The FDA acknowledges that toxic heavy metals in baby food are a public health concern. The agency has taken steps to address contamination, including the Closer to Zero action plan, which sets target levels for lead, arsenic, cadmium, and mercury in baby foods and proposes phased reductions over time.

However, the FDA has not set binding maximum levels for heavy metals in most baby food products (with the exception of inorganic arsenic in infant rice cereal, which the FDA capped at 100 ppb). The absence of enforceable limits is part of the litigation narrative: the plaintiffs argue that manufacturers exploited the regulatory gap, selling products with heavy metal levels that no reasonable standard would permit.

The defendants point to the FDA's Closer to Zero framework as evidence that the agency is managing the risk at levels the FDA considers appropriate, and that the products complied with applicable regulations (since, for most metals in most products, no binding limits existed).

Practical guidance

For parents evaluating a potential claim:

The litigation is active but faces substantial causation hurdles after the February 2026 expert exclusion. The cases have not been dismissed, and the plaintiffs' attorneys are working to develop new expert evidence, but the current posture makes near-term trial outcomes uncertain.

The strongest claims involve children who consumed substantial quantities of specific baby food products over an extended period and who were subsequently diagnosed with ASD, ADHD, or developmental delays. Medical records documenting the diagnosis, purchase records or consumption estimates for the specific products, and a timeline linking the consumption period to the developmental trajectory are the foundation.

Statute of limitations considerations are important. Statutes for product liability claims vary by state and may be measured from the date of injury, the date of diagnosis, or the date of discovery of the connection to the baby food. Because the children's diagnoses often occur years after the baby food consumption, the discovery rule may extend the limitations period, but prompt consultation with counsel is advisable.

Be cautious about advertising that overstates the litigation's prospects. The expert exclusion is a real setback, and the causation challenge is genuine. Counsel who are transparent about the current legal posture and who are actively working on the exposure-methodology problem are the appropriate contacts.

The toxic baby food litigation is important regardless of its legal outcome, because the Congressional investigations and the litigation discovery have forced transparency about contamination levels that were previously invisible to consumers. The contamination is documented; the legal challenge is proving that specific quantities caused specific injuries in specific children. That challenge is the litigation's central problem, and its resolution will determine whether the cases proceed to trial or settle.

Declan DoyleMass Tort Litigation

Declan covers active MDL litigation, qualification criteria, and settlement mechanics. He follows dockets and bellwether outcomes closely so readers understand where a case actually stands rather than what an ad promises.

Reviewed by Yuki Nakamura, JD
General information, not legal, tax, or financial advice. Laws and procedures vary by state and change over time, and every situation is different. Confirm current rules with the relevant agency or court, and consult a licensed attorney or other qualified professional before acting on anything you read here.

More in Mass Tort
Mass tort12 min
Social media youth mental health litigation MDL 3047: the 2,500+ cases against Meta, TikTok, Snapchat, and YouTube, the $6 million KGM bellwether verdict, the school district claims, and the addictive design theory
Declan Doyle · reviewed by Yuki Nakamura, JD
Mass tort11 min
Uber and Lyft sexual assault litigation MDL 3084: the 3,400+ pending cases, the $8.5 million bellwether verdict, the apparent-agency theory, and the separate Lyft MDL 3171
Declan Doyle · reviewed by Yuki Nakamura, JD
Mass tort11 min
Proton pump inhibitor kidney damage litigation MDL 2789: the $590 million in settlements, the 11,300 cases still pending, the AstraZeneca $425 million resolution, and the Takeda and P&G claims still in play
Declan Doyle · reviewed by Yuki Nakamura, JD